Dr. Bolwell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273Fax+1 216-444-9774
Summary
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1984 - 1987
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1981 - 1984
- Case Western Reserve University School of MedicineClass of 1981
- Harvard UniversityB.A., 1977
Certifications & Licensure
- OH State Medical License 1981 - 2025
- PA State Medical License 1984 - 1996
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Join now to see all
Clinical Trials
- Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Start of enrollment: 2003 Dec 01
- Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma Start of enrollment: 2002 Feb 01
- VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL Start of enrollment: 2000 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsClonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders.Hussein Awada, Carmelo Gurnari, Valeria Visconte, Arda Durmaz, Teodora Kuzmanovic
Leukemia. 2024-06-01 - 2 citationsInfluence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia.Sanghee Hong, Lisa Rybicki, Aiwen Zhang, Dawn Thomas, Cassandra M Kerr
Transplantation and Cellular Therapy. 2021-08-08 - 6 citationsHealth-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe StudyGalen E. Switzer, Jessica G. Bruce, Deidre M. Kiefer, Hati Kobusingye, Kaleab Z. Abebe
Biology of Blood and Marrow Transplantation. 2020-12-01
Journal Articles
- Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell TransplantationDeepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature
Abstracts/Posters
- Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...Brian J. Bolwell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- 2012 Highlights of ASH in North America (San Francisco, CA)American Society of Hematology (ASH), San Francisco, California - 2/3/2012
Press Mentions
- President Biden’s Cabinet Members Confirmed, HVO Presents Golden Apple Awards, and MoreMay 1st, 2021
- Cleveland Clinic Names Dr. Brian Bolwell to New Physician Leadership RoleApril 8th, 2021
- How US News' Best Hospitals for Cancer Care Are Improving Patient OutcomesSeptember 8th, 2020
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: